Wall Street is positive on BioCardia Inc (BCDA). On average, analysts give BioCardia Inc a Strong Buy rating. The average price target is $12.875, which means analysts expect the stock to increase by 276.46% over the next twelve months.
That average ranking earns BioCardia Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With BioCardia Inc Stock Today?
BioCardia Inc (BCDA) stock is trading at $3.42 as of 10:13 AM on Monday, Dec 14, a gain of $0.60, or 21.28% from the previous closing price of $2.82. The stock has traded between $3.05 and $3.94 so far today. Volume today is above average. So far 298,143 shares have traded compared to average volume of 99,377 shares.